According to ECHA’s study on the Socio-economic impacts of REACH authorizations, Out of 54 chemicals subject to authorization, and the use of almost half has stopped altogether in the EU. Furthermore, the review of existing authorizations shows that even where the use of some chemicals has continued, use volumes have reduced by 97%. This indicates that uses of authorized chemicals have been extensively replaced the study estimates the societal benefits of authorizing SVHC uses to be almost 20 times greater than the remaining health risks. The benefits relate to the availability of products and services, business maintenance, and jobs within the EU. The authorization requirement, together with conditions recommended by ECHA’s scientific committees, has helped reduce the risks of continued use of SVHCs to people’s health and the environment. Thus, ECHA says the authorization requirement has pushed companies to move away from using substances of very high concern (SVHCs).

Reference: https://echa.europa.eu/